Physician profile
Joe E Dib
NPI 1700820933
$1,105.73
in general payments reported to CMS, 2019-2025
12 companies · $45.02 in 2025
The $45.02 reported for 2025 was less than what a typical Emergency Medicine provider received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $334 · 2020: $214 · 2021: $164 · 2022: $27.72 · 2023: $273 · 2024: $47.91 · 2025: $45.02.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $366.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $366.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $253.12 | 2021-2023 | Dalvance |
| Allergan, INC. | $204.71 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $196.60 | 2019-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $109.53 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $108.35 | 2023 | |
| Astrazeneca Pharmaceuticals Lp | $71.15 | 2019-2024 | Andexxa, Fasenra |
| Pfizer INC. | $47.17 | 2020-2025 | |
| Vapotherm INC | $29.73 | 2019 | |
| Gilead Sciences, INC. | $27.90 | 2021-2022 | |
| Stryker Corporation | $27.14 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Alexion Pharmaceuticals, INC. | $16.49 | 2021 | |
| Merck Sharp & Dohme LLC | $13.84 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joe Dib listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.